Improving Public Health Via The Information Superhighway

The world is becoming healthier. Since the end of World War II, life expectancy in most developed and developing countries has increased by almost 25 years. This increase is the greatest seen in the history of the world. It has been estimated that almost 24 years of the 25-year increase are the result of improvements in public health and disease prevention. Such activities include improving sanitation, immunizing more people, bettering maternal and child health, and promoting healthier lifestyl

Written byRonald Laporte
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The world is becoming healthier. Since the end of World War II, life expectancy in most developed and developing countries has increased by almost 25 years. This increase is the greatest seen in the history of the world. It has been estimated that almost 24 years of the 25-year increase are the result of improvements in public health and disease prevention. Such activities include improving sanitation, immunizing more people, bettering maternal and child health, and promoting healthier lifestyles. We in public health have been doing something right. How can we maintain these advances and improve public health in the 21st century beyond what has been achieved to this point? The answer lies in the information superhighway (R.E. LaPorte et al., British Medical Journal, 308:1651-2, 1994).

A major component of public health and disease prevention is information exchange. Almost all public health preventive actions-such as undertaking surveillance of infectious and chronic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies